GSK will split into two new companies in 2022, they are GSK and Haleon. So what does this spin-off mean for Malaysia and the healthcare industry? Philip See speaks to Dr. Jonathan Pan, Vice President and GM of Malaysia and Brunei at GSK about their top-selling drugs, their role in the Covid-19 pandemic, and can Malaysia be a vaccine manufacturing hub?

How the US-Iran War Shook the Global Sukuk Market
29:58

Can foodpanda Win Without a Super App?
43:23

Puspakom Shifts Gears as Rivals Join the Race
23:49